About AIER News Social Responsibility
Professor Peng Xiaoyan, a renowned specialist in fundus and difficult eye diseases, joins Aier Hospital Group Caring for veterans' eye health, "Warmth for veterans - Guarding the light" public welfare action launched in Beijing Accelerating the accumulation of data assets and popularizing high-level ophthalmic medical services with artificial intelligence - AIER continues to work with the Chinese Academy of Sciences on digital ophthalmology development strategies The first new generation of astigmatism-correcting cataract surgery in China was successfully completed at AIER Prof. Zheng Wang has been invited to become a Fellow of the World College of Refractive Surgery and Vision Science (WCRS)! Ministry of Science and Technology's key research and development project lands in AIER for the first time, focusing on myopia prevention and control Talent planning - AIER launched the "Beidou talent plan", to build a global ophthalmic talent ecosystem The alliance between giants - AIER and China Eye Valley shows a sound momentum of all-round and in-depth eye health development AIER will donate 20 billion yuan in the next ten years to build a sustainable eye healthcare ecosystem Living up to our responsibility！ AIER received the Top 500 Chinese Brand Value Award with the "Huapu Award" for three consecutive years The research results of Prof. Jiansu Chen and Shibo Tang’s team from AIER were published in the International journal (impact factor: 10.633) Professor Fengyuan Sun, an oculoplastic & orbit disease expert in China, joined AIER to build the "Last Stop" for the diagnosis and treatment of intractable diseases 2021 AIER EYE HOSPITAL GROUP CO., LTD. Social Responsibility Report Prof. Weizhong Lan from AIER was invited to WHO-ITU Be He@lthy, Be Mobile toolkit for the myopia launch meeting AIER Eye Hospital Group donates 2 million yuan to Suzhou fight against the pandemic — Caring donation before Suzhou AIER Eye Hospital officially open AIER Eye Hospital Group received “The Red Cross Award of China” Prof. ZhiKuan Yang of AIER was elected president of the second council of Hunan Optometric Association Prof. Shibo Tang from AIER received the "China Industry-University-Research Collaboration Innovation and Promotion Award" AIER receives “Best Information Disclosure Award”by the Excellence IR School-enterprise cooperation making new progress by providing opportunities and platforms for talents to stand out - AIER and Henan University agreed to establish a strategic partnership AIER Clinic of Myopia Prevention for Teenagers: " 5P Model for Myopic Prevention" 6 billion RMB! A new university in Changsha - AIER International Medical College project signed Strategic Alliance Formed Between AIER and Sichuan University Protecting children and teenager’s eye health, "Red Cross Eye Protection Program " officially launched in Beijing Speech from Mr. Bang Chen on the China Charity Culture Forum: National consciousness and global mindset from AIER AIER Eye Hospital Group officially has a seat on the board of the World Association of Eye Hospital AIER won the "China Charity Awards" for two consecutive years Professor Jiansu Chen’s team from AIER researched the human corneal stromal cells from SMILE surgery The graduation ceremony of AIER School of Ophthalmology, CSU was held grandly, nearly 200 talents were trained in 6 years. The Rescue: AIER donates 5 million yuan to support disaster relief in Henan province. Malaysian Royal Datuk: Such a good doctor and team should be known to the world! From “poverty-alleviation” to “rural revitalization” AIER Is on the way to making brighter China mission possible Mr. Bang Chen, Chairman of AIER Eye Hospital Group, has been honored as "Excellent Builder of Socialism with Chinese Characteristics" ​Tianjin University AIER Eye Hospital opening ceremony was founded AIER and Singapore Eye Institute jointly tackle the key issues to build a whole chain of myopia research system Research team was led by principal of Jinan University, negotiating a tie-up cooperation with AIER. Optometry talent training accelerated; strategic alliance formed between Tianjin Vocational Institute & AIER Alliance between giants - AIER and the Chinese Academy of Sciences launch the STS "Smart Eye Care" project The number of SCI papers of AIER School of Ophthalmology CSU ranks among the top 20 in China Prospering in the pandemic : 2020's top 100 companies - AIER The awarding ceremony of "National Post-doctoral Research Workstation" of AIER was held in Changsha In the new round of national science & technology innovation platform construction, AIER is listed as the key cultivation object in Hunan Lan Wu, Deputy Secretary of the CPC Hunan Provincial Committee: Support AIER to grow bigger, benefit the eye health industry with more efforts. AIER is named as "The Most Influential 30 Listed Companies in 2020" Strategic Alliance Formed Between Anhui Medical University & AIER to Build a First-class Platform for Ophthalmology in Central China AIER Receives "Huapu Award" and "Anti-Epidemic Tribute Brand Enterprise" at China Brand Festival 2020 AIER Supports CSU with Double First-Class University Project, Rewarding All Medical Staff in Frontline Strategic Alliance Formed Between Jinan University & AIER to Build a First-class Platform for Ophthalmology Annual report of AIER Eye Hospital Group in 2019 Salute to all cornea donors Report of AIER's Fighting against COVID-19 Mourning to Doctor Li Wenliang AIER is Selected into CSI 100 Index International Retina Summit Forum 2019 Grandly opened, AIER Released the Big Data Report on Fundus Disease in Chinease Population Allied AIER & Novartis Establish an Innovative Mode for Chinese Eye Disease Diagnosis & Treatment Five AIER Eye Hospitals Certified by GCP AIER Selected as "Top 20 Competitive Chinese Pharmaceutical Listed Companies of 2019" Together We are Stronger - AIER & Alcon Global Strategic Cooperation Conference Held at Alcon Headquarter AIER Wins Bid for the 19th International Myopia Conference AIER: Exploring Innovation-Integrated Development Model, Sharing Global Vision AIER Acquires ISEC Group, One Big Step in the Belt&Road AIER's Talent Strategies for the Next Decade are Officially Released Led by AIER, the first National Hereditary Eye Diseases Committee is founded Huawei & Talkweb Join AIER to Build an Ophthalmic Medical Industry Ecosystem Enhance Innovation Ability, AIER Create a New Translation Model AIER Opens Up A New Era of Personalizing Myopia Prevent and Control Talent Strategy Helps "100-Year AIER" Dream AIER Eye Hospital Group was awarded the highest government award for charity - China Charity Award IOC - AIER Work Together for Training International High-end Ophthalmology Talents "Shigatse Charity Brightness Action" Helped Nearly 50 Tibetans Regain Their Vision AIER Eye Hospital Group Europe Holding Company Clinica Baviera Successfully Listed in Spain Focus on the New Trend of Global Refractive Surgery Grand opening of 2018 International Refractive Surgery Symposium AIER Eye Hospital Group Releases New Laser Surgery Technology-Smart 3D Prolonged Mobile Phone Use Accelerates the Incidence of Multiple Eye Diseases The Second Phase of "Lancang-Mekong Brightness Action" was Launched in Cambodia China Will Take the Lead to Solve the "Century Problem" of the Pathogenesis of Individual's Myopia AIER Eye Hospital Group is awarded China's Top 10 Investor-Respected Listed Company Aagain! Experts From AIER Have Gotten A Lot of Traction at Retina China 2018 Cooperating with Singapore National Eye Center and Singapore Eye Research Institute "China Bethune" is Famous Among Vietnamese AIER Institute for Corneal Disease Established, Dedicate to Improve China’s Medical Level for Corneal Diseases AIER Was Invited To Attend The Annual Conference Of The International Children's Vision Health Program Precision Anti-Poverty Operation: for 2000 Impoverished Patients in Xiangxi Breaking News: AIER Won the "2017 Excellent Public Welfare Project" Myopia Prevention and Control-Strategy & Perspective - Boao Forum for Vision 2017 2017 International Retina Summit (IRS) Closing AIER Reaches The Target of 200 Hospitals in Mainland China Earlier AIER’s Experts Won Awards at the 35th Congress of ESCRS Chinese Eye Hospital Group Completes Acquisition of Spanish Clinica Baviera "Visual Health Precision Poverty Alleviation Action" For Half a Million Impoverish Patients AIER Eye Hospital Group Acquired Clínica Baviera AIER Joints INTEL to Create Artificial Intelligence Eye Disease Identification Solutions Ieyecloud Private Eye Doctors Providing Signed Patients With Online Eye Health Services Big Data Technology, New Direction for Clinical Prevention and Control of Myopia AIER Eye Hospital Group Acquired AW Healthcare Management
International Retina Summit Forum 2019 Grandly opened, AIER Released the Big Data Report on Fundus Disease in Chinease Population

2019-11-18 00:00:00

On November 9, the 9th International Retina Summit Forum and the Nansha Eye Genetics Symposium was held in Nansha, Guangzhou. The conference was co-sponsored by AIER School of Ophthalmology · CSU and AIER Eye Hospital Group. Authoritative experts and scholars, who are famous in the field of Vitreous, retinal, optic nerve, ocular hereditary diseases, from North America, Europe, Southeast Asia and China gathered together to discuss new clinical diagnosis and treatment technologies and cutting-edge research results of retinal and ocular genetic diseases.

1.jpg

The 9th International Retina Summit Forum and the Nansha Eye Genetics Symposium.

Retinal diseases, including diabetic retinopathy, macular degeneration, retinitis pigmentosa, etc., have always been the main diseases that impair the health of human eyes. In the prevalence of globalization, diagnosis and treatment technologies for fundus need to keep pace with the rapid development of science and technology. Hence, close cooperation and communication with leading experts in the world is needed. The International Retina Summit Forum is a large, high-end, international platform that promotes and accelerates the exchange of scientific research and prevention technologies around the world.


Global experts gather together, contribute to a bright future

The International Retina Summit is held every two years and has been successfully held for eight times so far. Its influence and appeal are growing, and it has become one of the top events for retinal science internationally. In order to further expand the influence of the forum, the conference also innovatively implemented the "1+4" model: one main venue (Guangzhou) + four regional venues (Beijing, Shanghai, Chengdu, Urumqi). There are nearly a thousand experts and scholars in the ophthalmology industry, and more than one hundred speeches.


Four regional forums in Beijing, Sahnghai, Chengdu and Urumqi.

Prof. Tang Shibo, Chairman of this forum and Dean of AIER School of Ophthalmology · CSU, said: "This forum brings together the progress of new researches and new technological achievements for the treatment of retinal disease in the world, which will play an important role in promoting the treatment and research for retinal disease. In addition, the forum also included topics related to ocular genetic disease and will bring new hopes to many patients with retinal diseases and ocular hereditary diseases that were hopelessly untreatable."

7.jpg

Prof. Tang Shibo, Chairman of this forum and Dean of AIER School of Ophthalmology · CSU, delivers a speech.


Spotlighting Fundus, Exploring new remedy

It is reported that there are more than 100 well-known Chinese and foreign experts in the five conferences to share academic speeches and case. The speeches cover not only fundus diseases and ocular hereditary diseases, such as pathological myopia, macular degeneration, diabetic retinopathy, optic nerve defects, choroidal disease, macular hole, glaucoma, intraocular lymphoma and retinitis pigmentosa, but also include the application and research of stem cell therapy, minimally invasive vitrectomy, anti-VEGF drug therapy and artificial intelligence in the treatment of fundus diseases, focusing on today's cutting-edge developments and news in the field of retinal disease research in the world.


AIER released "Big Data Report on Fundus Disease in Chinese Population by AIER Eye Hospital Group" during the forum. Relying on the Leyecloud intelligent scanning and reading system invented by AIER, the research team examined 68,878 individuals' fundus via AI & remote reading in a year. This report shows that the number of people with fundus lesions is 12,620, and the rate of lesions is 18.32%. "The innovative service mode of AI + remote reading relieved the problem that the lack of ophthalmologist in remote area and communities. Combining AIER's medical strength of 400 hospitals in china mainland, this model will remedy the capacity of basic medical service for eye health in China, and effectively improve the eye health awareness of Chinese people.Besides, the data shows that fundus lesions becomes the primary factor of elderly blindness and male tends to ignore fundus lesions than female." Prof. Tang Shibo said.


68878人次的眼底阅片中，女性有45720人次，占比66.38%；男性有23158人次，占比33.62%;异常率为18.32%。
Among the 68,878 persons who was examined, there are 45,720 women (accounting for 66.38%) and 23,158 men (accounting for 33.62%);the rate of lesions is 18.32%.


At the same time, the "A Perspective Study on the Myopic Foveoschisis based on different surgical methods in real world" was launched in Shanghai. The project was initiated by Shanghai AIER Eye Hospital, and more than 40 ophthalmic medical institutions across the country participated in the study, aiming to develop a better treatment plan for Myopic Foveoschisis and benefit the majority of patients with high myopia.


10.jpg

The opening ceremony of "A Perspective Study on the Myopic Foveoschisis based on different surgical methods in real world" in Shanghai.